Corticosteroids significantly improve symptom score in patients with active pulmonary sarcoidosis over a two year follow up

H. Milburn, A. Warrington (London, United Kingdom)

Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Session: Different profiles of sarcoidosis and other granulomatous disorders
Session type: Thematic Poster Session
Number: 3733
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Milburn, A. Warrington (London, United Kingdom). Corticosteroids significantly improve symptom score in patients with active pulmonary sarcoidosis over a two year follow up. Eur Respir J 2011; 38: Suppl. 55, 3733

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does FEV1 deteriorate significantly between yearly follow-up assessments in chronic obstructive pulmonary disease?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010


Acute exacerbations significantly impair HRQL oof COPD patients, particularly in winter months
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002

Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008

Systemic inflammatory response during one year follow-up in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 13s
Year: 2004

Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade?
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with TDI-induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 604s
Year: 2005

One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007


Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011

Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004

Do COPD patients take timely measures in periods of symptom deterioration?
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia?
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Short outcome and evaluation of hemoptysis in patients with old pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 10s
Year: 2006

Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD
Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation
Year: 2006


The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS)
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Six months and one year follow up of COPD patients who had oral nutritional supplement therapy as a part of pulmonary rehabilitation program
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012


Tiotropium improved asthma symptoms and increased time to first exacerbation in patients with moderate-to-severe asthma.
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Sensitivity of the clinical COPD questionnaire to measure disease control in COPD patients referred for pulmonary rehabilitation
Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles
Year: 2008